Clinical Trials Directory

Trials / Completed

CompletedNCT00946868

Prevalence of Metabolic Syndrome in Patients With Intermittent Claudication

Status
Completed
Phase
Study type
Observational
Enrollment
170 (actual)
Sponsor
University of Sao Paulo · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Metabolic syndrome, a group of cardiovascular risk factors related to insulin resistance, is a major determinant of cardiovascular mortality. Intermittent claudication is a symptom of an early stage of atherosclerosis. The aim of this study is to determine the prevalence of the metabolic syndrome in patients with intermittent claudication and its correlation with age, gender, localization of arterial obstruction and association with coronary artery disease.

Detailed description

Studies correlating metabolic syndrome and several illnesses are being published, especially affections associated with atherosclerosis, like coronary artery disease, cerebrovascular disease and peripheral arterial disease. The term peripheral arterial disease, however, refers to several stages of the development of atherosclerosis in the extremities, comprising since asymptomatic patients as far as individuals with critical ischemia. Intermittent claudication is a symptom of an early stage of atherosclerosis, when medical interventions may still prevent the progression of the disease. Despite the importance of a precocious diagnosis of metabolic syndrome to initiate adequate treatment, its prevalence among these patients is not well determined in the literature. This is the biggest casuistic in the literature as far as we know.

Conditions

Timeline

Start date
2009-05-01
Primary completion
2009-07-01
Completion
2009-07-01
First posted
2009-07-27
Last updated
2009-07-27

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT00946868. Inclusion in this directory is not an endorsement.